ZEB1 and Uveal Melanoma Invasiveness
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262110346 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Maria Zhilnikova und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia. Hauptthemen laut MEDLINE: Zinc Finger E-box-Binding Homeobox 1, Melanoma, Uveal Neoplasms. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Uveal melanoma (UM) is the most prevalent primary intraocular tumor in adults. Transcription factor ZEB1 is one of the potential master regulators of melanocytes plasticity, because it is recognized as a “driver” of epithelial-to-mesenchymal transitions (EMTs) in carcinomas. We studied the correlation of tumor invasiveness with ZEB1 status and vascular endothelial growth factor/its receptor (VEGF-A/VEGFR2) in UM cells, and also with melanocyte’s differentiation rate. Eight UM cell cultures were characterized by melanosomes content using an ETM. ZEB1, VEGF-A and VEGFR2 levels in UM cells were detected by RT-PCR, Western blot, ELISA and flow cytometry. Effects of siRNA-dependent ZEB1 knockdown on UM cell proliferation and their sensitivity to the VEGF-A inhibitor Eylea (aflibercept) were tested by MTT and in a real-time proliferation assay. UMs with an invasive growth type can maintain a high degree of melanocyte differentiation. All ZEB1low cells were obtained from spindle cell tumors. The sensitivity of UM cells to Eylea inversely correlated with the level of the VEGFR2 receptor. ZEB1 knockdown completely blocked VEGF-A production while anti-VEGF treatment stimulated ZEB1 increase. In UM cell cultures, ZEB1 is a positive regulator of VEGF-A expression. In addition, there is probably a ZEB1 feedback loop that is sensitive to a drop in VEGF-A concentration. The data obtained allow us to consider ZEB1 silencing as an auxiliary link for a combined strategy of killing UM cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.
- Department of Natural Sciences, Novosibirsk State University, 630090 Novosibirsk, Russia.
- S. Fyodorov Eye Microsurgery Federal State Institution, Novosibirsk Branch, 630120 Novosibirsk, Russia.
ORCID-Profile: Sofia Zvereva, Mikhail Biryukov, Julia Poletaeva, Elena Ryabchikova, Olga Koval
Förderung
- Russian Science Foundation
Zitieren
APA
Zhilnikova, M., Balantaeva, M., Zvereva, S., Biryukov, M., Atamanov, V., Poletaeva, J., Ryabchikova, E., Stanishevskaya, O., Chernykh, D., Kononova, N., & Koval, O. (2025). ZEB1 and Uveal Melanoma Invasiveness. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110346
Vancouver
Zhilnikova M, Balantaeva M, Zvereva S, Biryukov M, Atamanov V, Poletaeva J, et al. ZEB1 and Uveal Melanoma Invasiveness. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110346
BibTeX
@article{Zhilnikova2025,
author = {Zhilnikova, Maria and Balantaeva, Maria and Zvereva, Sofia and Biryukov, Mikhail and Atamanov, Vasiliy and Poletaeva, Julia and Ryabchikova, Elena and Stanishevskaya, Olga and Chernykh, Dmitryi and Kononova, Natalia and Koval, Olga},
title = {ZEB1 and Uveal Melanoma Invasiveness},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262110346}
}
EUVIMED